4
Changes in Ownership
Milestone Pharmaceuticals Inc. Filed Acc 0001209191-22-020838
Options or other derivatives
- Chief Commercial Officer acquired 160,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Muller Lorenz Chief Commercial Officer | 2022-03-21 | Grant or award · Employee Stock Option Grant (right to buy) | +160,000 | 160,000 | D | ||
Loading xslF345X03/doc4.xml…